Cargando…
Mortality benefits and overdiagnosis estimates for women attending breast screening
Autores principales: | Ormiston-Smith, N, Scowcroft, H, Thomson, C S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681022/ https://www.ncbi.nlm.nih.gov/pubmed/23744279 http://dx.doi.org/10.1038/bjc.2013.260 |
Ejemplares similares
-
Estimation of lead time and overdiagnosis in breast cancer screening
por: Gøtzsche, P C, et al.
Publicado: (2009) -
Reply: Estimation of lead-time and overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2009) -
Overdiagnosis of breast cancer in Denmark
por: Zahl, P-H
Publicado: (2004) -
Reply: Overdiagnosis of breast cancer in Denmark
por: Olsen, A H, et al.
Publicado: (2004) -
Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography
por: Jacklyn, Gemma, et al.
Publicado: (2016)